Aurora Cannabis (ACB) Operating Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Operating Income of $3.0 million for Q1 2026, up 117.78% year-over-year from $1.4 million in Q1 2025, and down 78.77% quarter-over-quarter from $14.0 million in Q4 2025.
Aurora Cannabis (ACB) Operating Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Operating Income for 10 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income rose 117.78% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $18.8 million (up 161.89% YoY), while the FY2026 annual figure was -$34.0 million, down 1055.96% from the prior year.
- Operating Income declined to $3.0 million in Q1 2026 per ACB's latest filing, from $14.0 million in the prior quarter.
- Across five years, Operating Income topped out at $26.4 million in Q4 2024 and bottomed at -$4.8 billion in Q2 2023.
- Historically, Operating Income has averaged -$317.1 million across 5 years, with a median of -$4.9 million in 2023.
- Annual changes were most pronounced in 2023 — Operating Income sank 10000.51% — and 2024, when it soared 304.13%.
- Aurora Cannabis' Operating Income stood at -$129.2 million in 2022, then soared by 90.0% to -$12.9 million in 2023, then jumped by 304.13% to $26.4 million in 2024, then slumped by 46.83% to $14.0 million in 2025, then tumbled by 78.77% to $3.0 million in 2026.
- Business Quant data shows ACB's Operating Income at $3.0 million in Q1 2026, $14.0 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Aurora Cannabis | 235.30 Mn | 162.99 Mn | 25.75 Mn | 7.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.98 Mn |
| Dec 31, 2025 | 14.03 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | -1.09 Mn |
| Mar 31, 2025 | -16.75 Mn |
| Dec 31, 2024 | 26.38 Mn |
| Sep 30, 2024 | -1.75 Mn |
| Jun 30, 2024 | -717,248.88 |
| Mar 31, 2024 | -1.68 Mn |
| Dec 31, 2023 | -12.92 Mn |
| Sep 30, 2023 | -8.07 Mn |
| Jun 30, 2023 | -4.76 Bn |
| Dec 31, 2022 | -129.19 Mn |
| Sep 30, 2022 | -83.13 Mn |
| Jun 30, 2022 | -47.13 Mn |
| Mar 31, 2022 | -57.14 Mn |
| Dec 31, 2021 | -44.26 Mn |
| Sep 30, 2021 | -31.28 Mn |
| Jun 30, 2021 | -41.07 Mn |
| Mar 31, 2021 | -112.95 Mn |